Inclusion Criteria:  Pathologically-confirmed clinically localized prostate adenocarcinoma with National Comprehensive Cancer Network (NCCN) low (T1-T2a, Gleason 6, Grade Group 1, PSA <10 ng/mL) or intermediate risk (T2b-T2c or, Gleason 7, Grade Group 2 or 3 or PSA 10-20 ng/mL)72 at one of the selected hospitals in SCa and NYS Diagnosis date during the 18 month recruitment window Able to read/speak English or Spanish Agree to participate by completing the baseline questionnaire  Exclusion Criteria:  Clinically metastatic disease or high-risk PCa (T3a-T4, Gleason Grade Group 4 or 5 or PSA >20 ng/mL Unable to read/speak English or Spanish Unwilling or unable to give informed consent.